斑蝥类制剂治疗原发性肝癌的效益-风险评估
姜皓, 章之琪, 张冰, 张晓朦, 耿可欣
Benefit-Risk Assessment of Mylabris Preparations in the Treatment of Primary Hepatic Carcinoma
JIANG Hao, ZHANG Zhiqi, ZHANG Bing, ZHANG Xiaomeng, GENG Kexin
中国药物警戒
.
2021, (6): 525
-531
.
DOI: 10.19803/j.1672-8629.2021.06.07
